AGN wants too much..PFE will be back..too many synergies with GSK and the reduction in costs will pay for it over 10 years....GSK is too cheap to stay here
I am not a trader...I am a patent and biotech freak..I also speak to management and believe Henry is the real deal. In the canabis arena it is simple. You do not have to smoke much of our brand if we jack the drug content higher. That will speak volumes. Regarding selling the company. I doubt any tobacco company will be allowed to buy us. And if we get a Chantix like product partnered I can see a big Japanese drug company making a run. I think we are worth a lot more now than where we trade. It is why Soros and Goldman are sniffing.
This guy will redo the whole company and is smart enough to get a partner sooner than later. Lea and all the FDA folks are gone. It will take 90 days to see the new guy's posture but I like the fact he is already well off and the options are an inducement to a game he really knows how to play. Feel sorry for Knudson but he almost killed us by not understanding markets. I could almost see us partnering worldwide with a big device player and getting the funds to get a few more indications in the clinic. The power here is NOT vBloc. And Pharma I think this guy spent a good month doing due dilligence. Too bad he joins 11/16, after the call.
With all due respect MJNA is a joke...We are a scientific company while they are a marketing group. Ohio rejected canabis last night. Bounty towels trade higher than their stock.
Please do not post your buying prowess. No one cares and most of the time those claims are total bullschitte. If you are going say something don't tell us how many shares you own. Detracts from anything credible you have to add.
Pharma...one they have no capital and the US is a long slog..maybe a deal for international..get up front $ and a royalty..Why wait? Technology runs quicker than we can get sales in Europe. Brittain will not pay $15000...I know three surgeons there. It is socialized medicine and it is the poor people who are obese. Personally I would opt for selling vBloc and get on with other indications but lets see how this guy plays out..
Cost cutting????? We are introducing a new product...We have to cut costs because the dopes didn't raise capital. Cut costs....no...we had to cut costs...
The guy is smart and makes deals. He obviously knows we are capital anemic so I beieve he will address that first. He will get in his own people by Q1. He knows we can't sell the device for $15,000 and he knows we can't sell it internationally. My fervent hope is that he understands our technology is worth more than vBloc. There are millions floating out there for neuro-blocking technology and I hope he can find some for us. I can't fathom why existing management which supposedly had all these government contacts could do nothing. We are NOT AN OBESITY company and if he comes at it from that perspective we are in for quite a ride. If he can structure a deal with a big pharma company on a new indication our stock will rocket.
Just to set the record straight. Provenge did not and does not work. vBloc works. Trials of Provenge after approval actually had some serious side effects which were never disclosed. DNDN should have gone broke.
Well. they surprised me and found a risk player.The inducement was the only way. I just hope he understands technology more than singular devices. He ran and sold a lot of companies so he comes in heads above the present management. He hopefully will run the call.
Hey Pharma...What do you think about the company selling vBloc? Right now I think the technology is worth a lot more than the device which they have over priced and have no chance in my opinion of market penetration. No one here talks about the science and they still think we are an obesity company. Why didn;t we call our selves Obesitimedics!
Think I will check out for a while and see what these folks say in Noivember.
nbc news had a piece wednesday night where a vape cigarette exploded and some guy is in a coma..
yeah that stuff is great...
This is only the beginning. Neurostimulation is a new huge area. NO DRUGS. No side effects...But I am amazed how dumb the big pharma companies are. Idiots like PFE want to buy Allergan...
Yoiu are thinking too narrow..."obestity space." Our technology has a massive arena. ETRM screwed up as they never opened other indications but they were smart enough to tie up the patents..
vBloc and obesity are yesterday's discussions...Competition in the obestiy space will never stop. In neuroblocking technology it is just starting and we have a huge lead...